Comparative Analysis of Immunization and Immunization Coverage in Children of Russian Federation Federal Districts
https://doi.org/10.15690/pf.v18i6.2351
Abstract
Background. One of the effective ways to maintain the epidemic well-being of vaccine preventable diseases is to estimate immunization rates and coverage.
Objective. The aim of the study is to conduct comparative analysis of immunization levels among children in various regions of Russian Federation. Methods. Children aged from 6 months to 15 years conducted comparative analysis of indicators of documented immunization and immunization coverage according to forms 112/y and 036/y in four federal districts of Russian Federation. The immunization rate was estimated in individuals who had completed vaccination scheme according to the national immunization schedule (NIS) (of 2014). Immunization coverage was estimated by number of persons with at least one vaccination in past medical history.
Results. The analysis was performed on 2687 children medical records from the Central, Ural, Siberian and Volga federal districts (FD). BCG immunization rates in all FDs tend to be 100%. There are high levels of immunization against hepatitis B, as well as against measles, rubella and parotitis (the lowest values are noted in the Central Federal District: against hepatitis B — 74%, against measles, rubella, mumps — 69%, high — in the Volga Federal District: against hepatitis B — 95%, against measles, rubella, mumps — 97%). There is significant mismatch in immunization rates and immunization coverage for pertussis, diphtheria, tetanus and poliomyelitis in all FDs (from 20% to 40%) indicating that there are disturbances in vaccination schemes. Low immunization rates are noted against pneumococcal infection (from 12% in the Siberian Federal District to 36% in the Volga Federal District) and influenza (from 0.5% in the Volga Federal District to 9% in the Ural Federal District).
Conclusion. The highest immunization rates for all infections included in the NIS (apart from influenza) were revealed in the Volga Federal District. Influenza immunization rate is critically low in all FDs.
About the Authors
Polina R. GrinchikRussian Federation
MD, eLibrary SPIN: 3485-1401
1 Ostrovityanova Str., 117977, Moscow; +7 (915)262-04-00
Disclosure of interest:
absence of a reportable conflict of interests.
Leyla S. Namazova-Baranova
Russian Federation
MD, PhD, Professor, Academician of the RAS; eLibrary SPIN: 1312-2147
Moscow
Disclosure of interest:
Leyla S. Namazova-Baranova — receiving research grants from pharmaceutical companies Pierre Fabre LLC, GenzymeEurope B.V., AstraZeneca PLC, Gilead / PRA “Pharmaceutical Research Associates CIS”, Teva Branded Pharmaceutical products R&D, Inc / “PPD Development LLC (Smolensk)” LLC, “Stallerzhen S.A.” / “Quintiles GMBH” (Austria), Sanofi Aventis Group, “Bionorica”, “Nutricia”
Marina V. Fedoseenko
Russian Federation
MD, PhD, eLibrary SPIN: 6339-5386
Moscow
Disclosure of interest:
receiving fees from pharmaceutical companies Pfizer Innovations, Sanofi Aventis Group, MSD
Asiya A. Girina
Russian Federation
MD, PhD; eLibrary SPIN: 5751-7756
Disclosure of interest:
absence of a reportable conflict of interests.
Sergey V. Kovalev
Russian Federation
MD, PhD
Disclosure of interest:
absence of a reportable conflict of interests.
Anastasia V. Mazokha
Russian Federation
MD
Barnaul
Disclosure of interest:
absence of a reportable conflict of interests.
Elena D. Makushina
Russian Federation
MD, PhD
Moscow
Disclosure of interest:
absence of a reportable conflict of interests.
Elena I. Malinina
Russian Federation
MD, PhD; eLibrary SPIN: 9934-2702
Disclosure of interest:
absence of a reportable conflict of interests.
Anastasia Yu. Musikhina
Russian Federation
MD, PhD
Perm
Disclosure of interest:
absence of a reportable conflict of interests.
Olga A. Perminova
Russian Federation
MD, PhD;eLibrary SPIN: 4328-4968
Perm
Disclosure of interest:
absence of a reportable conflict of interests.
Nina Y. Plenskovskaya
Russian Federation
MD, PhD
Moscow
Disclosure of interest:
absence of a reportable conflict of interests.
Tatiana E. Privalova
Russian Federation
MD, PhD;eLibrary SPIN: 7879-4299
Moscow
Disclosure of interest:
receiving fees from pharmaceutical companies MSD, “Bionorica”, “Nutricia”
Aleksei Yu. Rtishchev
Russian Federation
MD, PhD; eLibrary SPIN: 3636-7769
Moscow
Disclosure of interest:
receiving fees from pharmaceutical companies Pfizer Innovations, Sanofi Aventis Group, MSD
Dina S. Rusinova
Russian Federation
MD, PhD; eLibrary SPIN: 8726-6132
Moscow
Disclosure of interest:
absence of a reportable conflict of interests.
Olga A. Rychkova
Russian Federation
MD, PhD; eLibrary SPIN: 1382-1555
Disclosure of interest:
absence of a reportable conflict of interests.
Vladislav V. Semerikov
Russian Federation
MD, PhD; eLibrary SPIN: 8045-4451
Disclosure of interest:
absence of a reportable conflict of interests.
Maria V. Fominykh
Russian Federation
MD
Moscow
Disclosure of interest:
absence of a reportable conflict of interests.
Denis S. Fugol
Russian Federation
MD, PhD; eLibrary SPIN: 8586-4000
Barnaul
Disclosure of interest:
receiving fees from pharmaceutical company “Nutricia”
Nadezhda V. Yakimova
Russian Federation
MD, PhD
Disclosure of interest:
absence of a reportable conflict of interests.
References
1. Gualano MR, Olivero E, Voglino G, et al. Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Hum Vaccin Immunother. 2019;15(4):918–931. doi: https://doi.org/10.1080/21645515.2018.1564437
2. Pandolfi F, Franza L, Todi L, et al. The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases. Curr Med Chem. 2018;25(42):6070–6081. doi: https://doi.org/10.2174/0929867325666180518072730
3. Kennedy J. Vaccine Hesitancy: A Growing Concern. Paediatr drugs. 2020;22(2):105–111. doi: https://doi.org/10.1007/s40272-020-00385-4
4. Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA. 2016;315(11):1149–1158. doi: https://doi.org/10.1001/jama.2016.1353
5. Schwartz JL. Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease Outbreaks. JAMA Pediatr. 2018; 172(9):805–807. doi: https://doi.org/10.1001/jamapediatrics.2018.2238
6. Decree of the President of the Russian Federation dated May 7, 2018 № 204 “O natsional’nykh tselyakh i strategicheskikh zadachakh razvitiya Rossiiskoi Federatsii na period do 2024 goda”. (In Russ). Доступно по: http://www.garant.ru/products/ipo/prime/doc/71837200. Ссылка активна на 01.10.2020.
7. Briko NI, Brazhnikov AYu, Kiryanova EV, et al. Klinicheskaya epidemiologiya i osnovy dokazatel’noi meditsiny / Briko NI, ed. — Moscow: Remedium Volga Region Publishing House; 2019. (In Russ).
8. Cutts FT, Claquin P, Danovaro-Holliday MC, Rhoda DA. Monitoring vaccination coverage: Defining the role of surveys. Vaccine. 2016;34(35):4103–4109. doi: https://doi.org/10.1016/j.vaccine.2016.06.053
9. WHO. Global Vaccine Action Plan. In: World Health Organization. 14 June 2020. Available online: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/global-vaccine-actionplan. Accessed on February 26, 2022.
10. Namazova-Baranova LS, Fedoseenko MV, Grinchik PR, et al. Immunization and Immunization Coverage According to National Immunization Schedule for Children Population: Cross-Sectional Multi-Centre Study. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2021;18(2):110–117. (In Russ). doi: https://doi.org/10.15690/pf.v18i2.2218
11. Hajj Hussein I, Chams N, Chams S, et al. Vaccines Through Centuries: Major Cornerstones of Global Health. Front Public Health. 2015;3:269. doi: https://doi.org/10.3389/fpubh.2015.0026918ORIGINALARTICLES ОРИГИНАЛЬНЫЕ СТАТЬИ
12. Doherty M, Buchy P, Standaert B, et al. Vaccine impact: Benefits for human health. Vaccine. 2016;34(52):6707–6714. doi: https://doi.org/10.1016/j.vaccine.2016.10.025
13. MU 3.1.1082-01. Epidemiologicheskii nadzor za difteriinoi infektsiei: Methodological guidelines. Moscow: Federal Center for State Sanitary and Epidemiological Supervision of the Ministry of Health of Russia; 2002. 24 p. (In Russ).
14. MU 3.1.2.1177-02. Epidemiologicheskii nadzor za kor’yu, krasnukhoi i epidemicheskim parotitom: Methodological guidelines. Moscow: Federal Center for State Sanitary and Epidemiological Supervision of the Ministry of Health of Russia; 2003. 34 p. (In Russ).
15. WHO. Global Health Observatory data. Causes of Child Mortality, 2017. In: World Health Organization. Available online: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/childmortality. Accessed on Marth 30, 2021.
16. Rosini R, Nicchi S, Pizza M, Rappuoli R. Vaccines Against Antimicrobial Resistance. Front Immunol. 2020;11:1048. doi: https://doi.org/10.3389/fimmu.2020.01048
17. Tagliabue A, Rappuoli R. Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top. Front Immunol. 2018;9:1068. doi: https://doi.org/10.3389/fimmu.2018.01068
18. Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018; 14(9):2142–2149. doi: https://doi.org/10.1080/21645515.2018.1476814
19. Reuben R, Aitken D, Freedman JL, Einstein G. Mistrust of the medical profession and higher disgust sensitivity predict parental vaccine hesitancy. PLoS One. 2020;15(9):e0237755. doi: https://doi.org/10.1371/journal.pone.0237755
20. Kaliuzhnaia TA, Fedoseen ko MV, Namazova-Baranova LS, et al. Overcoming ‘Anti-Vaccination Scepticism’: Seeking a Solution to the Situation. Pediatriches kaya farmakologiya — Pediatric pharmacology. 2018;15(2):141–148. (In Russ). doi: https://doi.org/10.15690/pf.v15i2.1871
21. Porter A, Goldfarb J. Measles: A dangerous vaccine-preventable disease returns. Cleve Clin J Med. 2019;86(6):393–398. doi: https://doi.org/10.3949/ccjm.86a.19065
22. Paniz-Mondolfi AE, Tami A, Grillet ME, et al. (2019). Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas. Emerg Infect Dis. 2019;25(4): 625–632. doi: https://doi.org/10.3201/eid2504.181305
23. Dreisinger N, Lim CA. Resurgence of Vaccine-Preventable Disease: Ethics in the Pediatric Emergency Department. Pediatr Emerg Care. 2019;35(9):651–653. doi: https://doi.org/10.1097/PEC.0000000000001917
24. Martin C, Aguilo N, Gonzalo-Asensio J. Vaccination against tuberculosis. Vacunación frente a tuberculosis. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36(10):648–656. doi: https://doi.org/10.1016/j.eimc.2018.02.006
25. Gault G, Fischer A, Nicand E, et al. Assessment of vaccination coverage of adolescents aged 16-18 years with an innovative electronic immunization record system. Med Mal Infect. 2019;49(1): 38–46. doi: https://doi.org/10.1016/j.medmal.2018.11.001
26. Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kang Y. Vaccination Coverage Among Children Aged 19-35 Months — United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(40):1123–1128. doi: https://doi.org/10.15585/mmwr.mm6740a4
27. Khan J, Shil A, Mohanty SK. Hepatitis B vaccination coverage across India: exploring the spatial heterogeneity and contextual determinants. BMC Public Health. 2019;19(1):1263. doi: https://doi.org/10.1186/s12889-019-7534-2
28. Strategic Advisory Group of Experts on Immunization. Assessment report on the implementation of the Global Vaccine Action Plan 2018. Geneva: World Health Organization; 2018. Available online: https://www.who.int/immunization/newsroom/news_release_gvap_2018_assessment_report/en. Accessed on Marth 30, 2021.
29. MU 3.3.1889-04. Poryadok provedeniya profilakticheskikh privivok: Methodological guidelines. Moscow: Federal Center for State Sanitary and Epidemiological Supervision of the Ministry of Health of Russia; 2004. 32 p. (In Russ).
30. Mukozheva RA, Kulichenko TV, Vilchanskaya TV, et al. Analysis of Vaccination of Children and its Timing Against Infections from the National Immunization Schedule in the Volga and Far Eastern Federal Districts of Russian Federation: CrossSectional Study. Voprosy sovremennoi pediatrii — Current Pediatrics. 2021;20(3):282–291. (In Russ). doi: https://doi.org/10.15690/vsp.v20i4.2284
Review
For citations:
Grinchik P.R., Namazova-Baranova L.S., Fedoseenko M.V., Girina A.A., Kovalev S.V., Mazokha A.V., Makushina E.D., Malinina E.I., Musikhina A.Yu., Perminova O.A., Plenskovskaya N.Y., Privalova T.E., Rtishchev A.Yu., Rusinova D.S., Rychkova O.A., Semerikov V.V., Fominykh M.V., Fugol D.S., Yakimova N.V. Comparative Analysis of Immunization and Immunization Coverage in Children of Russian Federation Federal Districts. Pediatric pharmacology. 2022;19(1):6-19. (In Russ.) https://doi.org/10.15690/pf.v18i6.2351